We use cookies for a better user experience. Read our Privacy Policy

I Agree

Central Lab Market

Central Lab Market (Product: Genetic Services, Biomarker Services, Microbiology Services, Specimen Management & Storage, Clinical Research & Trial Services, and Others, and End-user) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Central Lab Market Outlook 2031

  • The global central lab market was valued at US$ 2.3 Bn in 2020
  • It is estimated to expand at a CAGR of 5.4% from 2021 to 2031
  • The global central lab market is expected to reach the value of US$ 4 Bn by the end of 2031

Analysts’ Viewpoint on Central Lab Market Scenario

Companies in the central lab market are increasing efforts to implement home visit testing for several COVID-19 research studies and provide high quality support to logistics courier partners. Investigator site portals are providing intuitive and interactive tools for central lab sites in order to manage registered samples, subject enrollment, order collection kits, and the likes. Electronic lab requisition reduces the risk of sample loss by enabling a chain of custody before the sample leaves the clinic. However, study teams face complexities such as working with niche laboratories to evaluate decentralized clinical trial designs. Thus, to overcome these challenges, companies should transition toward AI, Blockchain, and automation technologies in laboratory trials management systems and for sample tracking.

Standardized Methods in Central Labs Aiding in Achieving Operational Excellence

Efficient service and quality data without compromise have become important focus points for companies in the central lab market. Companies are increasing efforts to streamline auditing, deviation management, and standard operating procedures.

Stakeholders in the market are committing to operational excellence in order to comply with the global standards as suggested by the College of American Pathologists (CAP), the Clinical Laboratory Improvement Amendments (CLIA), and the likes. As such, real-time central lab database management platforms are becoming a recurring market trend, since it can be automatically integrated with the patient or medical data of a clinical trial management system.

Request a sample to get extensive insights into the Central Lab Market

Stakeholders Closely Monitoring Lab Testing Processes amid COVID-19 Pandemic

Companies in the central lab market have been under scrutiny for minimizing potential disruptions to the logistical movements of human samples and potential supply issues for clinical kits during the ongoing COVID-19 pandemic. Stakeholders of central laboratory support services are increasing efforts to closely work with its logistics providers and courier partners to implement alternative transportation solutions, owing to increased cost of transporting supplies.

Stakeholders in the market are collaborating with network laboratories to assess the current coronavirus situation and plan its potential impact on lab testing services. Laboratory vendors are closely monitoring and updating their business continuity plans in severely affected COVID-19 regions such as the U.K. and China. Stakeholders are working closely with their staff to monitor subject compliance.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Time Consuming Procedures and Lack of Training for Medical Professionals Affect Market Growth

The central lab market is predicted to witness high revenue growth throughout the assessment tenure. However, central lab stakeholders are posed with many challenges such as time consuming processes, as several sites samples need to reach one lab and may take several days. Hence, central labs are now sharing this responsibility with local lab facilities, whilst increasing R&D to adopt processes that accelerate their lab procedures.

On the other hand, the German healthcare system in the central lab market poses issue in invoicing medical services to non-physician medical specialists in hospitals due to the scarcity of medical professionals. Hence, the German Society for Laboratory Medicine (DGKL) is increasing efforts to provide additional training in a master program in laboratory medicine aimed at medical professionals to facilitate invoicing for lab services in hospitals.

Stuck in a neck-to-neck competition with other brands? Request a custom report on Central Lab Market

Tech Companies Innovating in Real-time Laboratory Information Data Portals

The central lab market is slated to register a favorable CAGR during the forecast period. Companies are making use of its real-time laboratory information data portals for investigator sites and sponsors to have access to the data for their user accounts. Lab professionals are increasing efforts to provide 24/7 secured access to clinical trial information and authorized data reports. Companies are collaborating with software developers to secure laboratory information data portals with encrypted connections.

Virtual Result Reporting Automation Translating into Revenue Opportunities for Central Labs

A plethora of technological and software innovations is storming the global central lab market. Clinical trial laboratory service organizations are supporting central labs with innovations such as artificial intelligence (AI) protocol reading, sample & consent tracking, and next-gen flow cytometry result reporting automation, among others.

Direct to patient kit shipments, blockchain for sample tracking, and electronic histology & pathology reports are benefitting stakeholders in the central lab market. They are unlocking growth opportunities for supporting decentralized virtual trials innovation. In order to achieve this, companies are partnering with mobile nurse and phlebotomy companies to enable in-home specimen collection from individuals and patients alike.

Central Lab Market: Overview

  • Most of the pharmaceutical companies are investing in the development of novel drugs and devices. The pharmaceutical industry, in particular, is R&D-intensive. Pharmaceutical companies invest in R&D to deliver high quality and innovative products to the market. The trend suggests that the top pharma companies are increasing their R&D efficiencies by increasing investments for assured returns in the long term and through collaborative R&D efforts. According to an Evaluate Pharma report, the global pharmaceutical R&D spending stood at US$ 136 Bn in 2012, which increased to US$ 186 Bn in 2019.
  • Increase in pharmaceutical R&D has resulted in a sharp increase in the number of cell & gene therapy candidates under development. This has made it necessary to outsource manufacturing services to develop cost-effective and efficient cell & gene therapies, which drives the central lab market.
  • The number of trials in Asia Pacific is increasing, and so has the use of remote clinical sites. Additionally, local regulatory issues around the shipment of human blood samples drive the need to have short (less than one day) shipping distances from clinical sites to lab testing facilities to ensure that samples could be rapidly tested in a central lab using globally standard equipment.
  • Earlier, most clinical trial laboratory testing was done by local laboratory, which was organized by individual principle investigator. Collecting data from multiple local laboratories that used different testing methodologies, reference ranges, and standard operating procedures (SOPs) was associated with data errors resulting in consequent delays and increased cost for sponsors.
  • Mismarked kits, incomplete samples, and inaccurate tests were common. The laboratory results received at the conclusion of the clinical trial revealed a very high error rate. This situation got even more complicated as the trial became globalized. Processing of data containing such inaccuracies leads to months of data cleaning work in order to make it analyzable.
  • Central labs train the site staff for proper collection, packaging, and labelling requirements, thereby reducing human errors, which can lead to miss identification and reporting of samples. Central laboratories standardize selection of proper method for analysis and equipment that indicate suitable blood volume to be collected and also standardize the final report formats. Hence, these factors drive the global central lab market.

Central Lab Market: Segmentation

  • In terms of product, the global central lab market has been classified into genetic services, biomarker services, microbiology services, anatomic pathology/histology, specimen management & storage, special chemistry services, clinical research & trial services, and others
  • Based on end-user, the global central lab market has been divided into pharmaceutical companies, biotechnology companies & academic, and research institutes
  • Each of the segments has been analyzed in detail for market trends, recent trends, and developments, drivers, restraints, opportunities, and useful insights. The central lab market report provides current and expected revenue (US$ Mn) for each of these segments from 2021 to 2031, considering 2020 as the base year. The compound annual growth rate (percentage CAGR) has been provided for each segment and market from 2021 to 2031, along with market size estimations.

Central Lab Market: Regional Overview

  • In terms of region, the global central lab market has been segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa
  • High adoption of technological advancements in North America backed up by proper quality measures play an important role in delivering quality, efficient, and effective service to the growing healthcare industry
  • Surge in the geriatric population, increase in patient awareness about the value of laboratory tests, and rise in prevalence of infectious & chronic diseases are the major factors driving the market in the region. According to the Centers for Disease Control and Prevention (CDC), in 2018, around 133 million people in the U.S., or 45% of the population, had, at least, one chronic disease. Chronic diseases are responsible for seven in 10 deaths, accounting for more than 1.7 million deaths in the country every year.

Central Lab Market: Major Players

  • The central lab market report concludes with the company profiles section, which includes key information about major players in the global central lab market
  • Leading players analyzed in the report include
    • ACM Global Central Lab
    • Barc Lab (Cerba Research)
    • Bioscientia (Sonic Healthcare)
    • Celerion
    • CIRION BioPharma Research
    • Clinical Reference Laboratory
    • Eurofins Central Laboratory
    • Frontage Laboratories, Inc.
    • ICON Central Labs.
    • INTERLAB Central Lab Services
    • InVitro International
    • Lab Corp/Covance
    • LabConnect
    • Medpace
    • MLM Medical Labs GmbH
    • PPD
    • Q² Solutions
    • Synevo Central Lab
  • Each of these players has been profiled in the central lab market report based on parameters such as company overview, financial overview, business strategies, application portfolio, business segments, and recent developments

Central Lab Market Snapshot

Attribute

Detail

Market Size Value in 2020

US$ 2.3 Bn

Market Forecast Value in 2031

US$ 4 Bn

Growth Rate (CAGR)

5.4%

Forecast Period

2021–2031

Quantitative Units

US$ Mn for Value

Market Analysis

It includes cross segment analysis at global as well as regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview.

Competition Landscape

  • Market player - Competition matrix (by tier and size of companies)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • Product
    • Genetic Services
    • Biomarker Services
    • Microbiology Services
    • Anatomic Pathology / Histology
    • Specimen Management & Storage
    • Special Chemistry Services
    • Clinical Research & Trial Services
    • Others
  • End-user
    • Pharmaceutical Companies
    • Biotechnology Companies
    • Academic & Research Institutes

Regions Covered

  • North America
  • Latin America
  • Europe
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • ACM Global Central Lab
  • Barc Lab (Cerba Research)
  • Bioscientia (Sonic Healthcare)
  • Celerion
  • CIRION BioPharma Research
  • Clinical Reference Laboratory
  • Eurofins Central Laboratory
  • Frontage Laboratories, Inc.
  • ICON Central Labs.
  • INTERLAB Central Lab Services.
  • InVitro International
  • Lab Corp/Covance
  • LabConnect
  • Medpace
  • MLM Medical Labs GmbH
  • PPD
  • Q² Solutions
  • Synevo Central Lab
  • Other prominent players

Customization Scope

Available upon request

Pricing

Available upon request

Central Lab Market – Segmentation

TMR’s study on the global central lab market includes information divided into three segments: product, end-user, and region. Changing industry trends and other market dynamics associated with these segments of the global central lab market are discussed in detail.

Product
  • Genetic Services
  • Biomarker Services
  • Microbiology Services
  • Anatomic Pathology / Histology
  • Specimen Management & Storage
  • Special Chemistry Services
  • Clinical Research & Trial Services
  • Others
End-user
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Academic & Research Institutes
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Central Lab Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of central lab market?

Central lab market is expected to reach the value of US$ 4 Bn by the end of 2031

What is the anticipated CAGR of the central lab market in the forecast period?

Central lab market is estimated to expand at a CAGR of 5.4% from 2021 to 2031

What are the key driving factors for the growth of the central lab market?

Central lab market is driven by rise in demand for biomarkers in diagnostic therapeutic across the globe

Which region is expected to project the highest market share in the global central lab market?

North America accounted for a major share of the global central lab market

Who are the key players in the global central lab market?

Key players operating in the global central lab market include ACM Global Central Lab, Barc Lab (Cerba Research), Bioscientia (Sonic Healthcare), Celerion, CIRION BioPharma Research

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Central Lab Market

4. Market Overview

    4.1. Introduction

        4.1.1. Product Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Central Lab Market Analysis and Forecast, 2017–2031

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

    5.2. Strategies Adopted by Top 3 Players

    5.3. Impact of Cell and Gene Therapy on Central Lab Market

    5.4. Impact of Clinical Trial on Central Lab Market

    5.5. Central Lab Market: SWOT Analysis

6. Global Central Lab Market Analysis and Forecast, by Product

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Product, 2017–2031

        6.3.1. Genetic Services

        6.3.2. Biomarker Services

        6.3.3. Microbiology Services

        6.3.4. Anatomic Pathology/Histology

        6.3.5. Specimen Management & Storage

        6.3.6. Special Chemistry Services

        6.3.7. Clinical Research & Trial Services

        6.3.8. Others

    6.4. Market Attractiveness Analysis, by Product

7. Global Central Lab Market Analysis and Forecast, by End-user

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by End-user, 2017–2031

        7.3.1. Pharmaceutical Companies

        7.3.2. Biotechnology Companies

        7.3.3. Academic and Research Institutes

    7.4. Market Attractiveness Analysis, by End-user

8. Global Central Lab Market Analysis and Forecast, by Region

    8.1. Key Findings

    8.2. Market Value Forecast, by Region

        8.2.1. North America

        8.2.2. Europe

        8.2.3. Asia Pacific

        8.2.4. Latin America

        8.2.5. Middle East and Africa

    8.3. Market Attractiveness Analysis, by Region

9. North America Central Lab Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

    9.2. Market Value Forecast, by Product, 2017–2031

        9.2.1. Genetic Services

        9.2.2. Biomarker Services

        9.2.3. Microbiology Services

        9.2.4. Anatomic Pathology/Histology

        9.2.5. Specimen Management & Storage

        9.2.6. Special Chemistry Services

        9.2.7. Clinical Research & Trial Services

        9.2.8. Others

    9.3. Market Value Forecast, by End-user, 2017–2031

        9.3.1. Pharmaceutical Companies

        9.3.2. Biotechnology Companies

        9.3.3. Academic and Research Institutes

    9.4. Market Value Forecast, by Country, 2017–2031

        9.4.1. U.S.

        9.4.2. Canada

    9.5. Market Attractiveness Analysis

        9.5.1. By Product

        9.5.2. By End-user

        9.5.3. By Country

10. Europe Central Lab Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Product, 2017–2031

        10.2.1. Genetic Services

        10.2.2. Biomarker Services

        10.2.3. Microbiology Services

        10.2.4. Anatomic Pathology/Histology

        10.2.5. Specimen Management & Storage

        10.2.6. Special Chemistry Services

        10.2.7. Clinical Research & Trial Services

        10.2.8. Others

    10.3. Market Value Forecast, by End-user, 2017–2031

        10.3.1. Pharmaceutical Companies

        10.3.2. Biotechnology Companies

        10.3.3. Academic and Research Institutes

    10.4. Market Value Forecast, by Country/Sub-region, 2017–2031

        10.4.1. Germany

        10.4.2. U.K.

        10.4.3. France

        10.4.4. Italy

        10.4.5. Spain

        10.4.6. Rest of Europe

    10.5. Market Attractiveness Analysis

        10.5.1. By Product

        10.5.2. By End-user

        10.5.3. By Country/Sub-region

11. Asia Pacific Central Lab Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Product, 2017–2031

        11.2.1. Genetic Services

        11.2.2. Biomarker Services

        11.2.3. Microbiology Services

        11.2.4. Anatomic Pathology/Histology

        11.2.5. Specimen Management & Storage

        11.2.6. Special Chemistry Services

        11.2.7. Clinical Research & Trial Services

        11.2.8. Others

    11.3. Market Value Forecast, by End-user, 2017–2031

        11.3.1. Pharmaceutical Companies

        11.3.2. Biotechnology Companies

        11.3.3. Academic and Research Institutes

    11.4. Market Value Forecast, by Country/Sub-region, 2017–2031

        11.4.1. Japan

        11.4.2. China

        11.4.3. India

        11.4.4. Australia & New Zealand

        11.4.5. Rest of Asia Pacific

    11.5. Market Attractiveness Analysis

        11.5.1. By Product

        11.5.2. By End-user

        11.5.3. By Country/Sub-region

12. Latin America Central Lab Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Product, 2017–2031

        12.2.1. Genetic Services

        12.2.2. Biomarker Services

        12.2.3. Microbiology Services

        12.2.4. Anatomic Pathology/Histology

        12.2.5. Specimen Management & Storage

        12.2.6. Special Chemistry Services

        12.2.7. Clinical Research & Trial Services

        12.2.8. Others

    12.3. Market Value Forecast, by End-user, 2017–2031

        12.3.1. Pharmaceutical Companies

        12.3.2. Biotechnology Companies

        12.3.3. Academic and Research Institutes

    12.4. Market Value Forecast, by Country/Sub-region, 2017–2031

        12.4.1. Brazil

        12.4.2. Mexico

        12.4.3. Rest of Latin America

    12.5. Market Attractiveness Analysis

        12.5.1. By Product

        12.5.2. By End-user

        12.5.3. By Country/Sub-region

13. Middle East and Africa Central Lab Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Product, 2017–2031

        13.2.1. Genetic Services

        13.2.2. Biomarker Services

        13.2.3. Microbiology Services

        13.2.4. Anatomic Pathology/Histology

        13.2.5. Specimen Management & Storage

        13.2.6. Special Chemistry Services

        13.2.7. Clinical Research & Trial Services

        13.2.8. Others

    13.3. Market Value Forecast, by End-user, 2017–2031

        13.3.1. Pharmaceutical Companies

        13.3.2. Biotechnology Companies

        13.3.3. Academic and Research Institutes

    13.4. Market Value Forecast, by Country/Sub-region, 2017–2031

        13.4.1. GCC Countries

        13.4.2. South Africa

        13.4.3. Rest of Middle East and Africa

    13.5. Market Attractiveness Analysis

        13.5.1. By Product

        13.5.2. By End-user

        13.5.3. By Country/Sub-region

14. Competition Landscape

    14.1. Market Player - Competition Matrix (by tier and size of companies)

    14.2. Market Share Analysis, by Company, 2020

    14.3. Company Profiles

        14.3.1. ACM Global Central Lab

            14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.1.2. Company Financials

            14.3.1.3. Growth Strategies

            14.3.1.4. SWOT Analysis

        14.3.2. Barc Lab (Cerba Research)

            14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.2.2. Company Financials

            14.3.2.3. Growth Strategies

            14.3.2.4. SWOT Analysis

        14.3.3. Bioscientia (Sonic Healthcare)

            14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.3.2. Company Financials

            14.3.3.3. Growth Strategies

            14.3.3.4. SWOT Analysis

        14.3.4. Celerion

            14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.4.2. Company Financials

            14.3.4.3. Growth Strategies

            14.3.4.4. SWOT Analysis

        14.3.5. CIRION BioPharma Research

            14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.5.2. Company Financials

            14.3.5.3. Growth Strategies

            14.3.5.4. SWOT Analysis

        14.3.6. Clinical Reference Laboratory

            14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.6.2. Company Financials

            14.3.6.3. Growth Strategies

            14.3.6.4. SWOT Analysis

        14.3.7. Eurofins Central Laboratory

            14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.7.2. Company Financials

            14.3.7.3. Growth Strategies

            14.3.7.4. SWOT Analysis

        14.3.8. Frontage Laboratories, Inc.

            14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.8.2. Company Financials

            14.3.8.3. Growth Strategies

            14.3.8.4. SWOT Analysis

        14.3.9. ICON Central Labs.

            14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.9.2. Company Financials

            14.3.9.3. Growth Strategies

            14.3.9.4. SWOT Analysis

        14.3.10. INTERLAB Central Lab Services.

            14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.10.2. Company Financials

            14.3.10.3. Growth Strategies

            14.3.10.4. SWOT Analysis

        14.3.11. InVitro International

            14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.11.2. Company Financials

            14.3.11.3. Growth Strategies

            14.3.11.4. SWOT Analysis

        14.3.12. Lab Corp/Covance

            14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.12.2. Company Financials

            14.3.12.3. Growth Strategies

            14.3.12.4. SWOT Analysis

        14.3.13. LabConnect

            14.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.13.2. Company Financials

            14.3.13.3. Growth Strategies

            14.3.13.4. SWOT Analysis

        14.3.14. Medpace

            14.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.14.2. Company Financials

            14.3.14.3. Growth Strategies

            14.3.14.4. SWOT Analysis

        14.3.15. MLM Medical Labs GmbH.

            14.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.15.2. Company Financials

            14.3.15.3. Growth Strategies

            14.3.15.4. SWOT Analysis

        14.3.16. PPD

            14.3.16.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.16.2. Company Financials

            14.3.16.3. Growth Strategies

            14.3.16.4. SWOT Analysis

        14.3.17. Q² Solutions

            14.3.17.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.17.2. Company Financials

            14.3.17.3. Growth Strategies

            14.3.17.4. SWOT Analysis

        14.3.18. Synevo Central Lab

            14.3.18.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.18.2. Company Financials

            14.3.18.3. Growth Strategies

            14.3.18.4. SWOT Analysis

        14.3.19. Other Prominent Players

            14.3.19.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.19.2. Company Financials

            14.3.19.3. Growth Strategies

            14.3.19.4. SWOT Analysis

List of Tables

Table 01: Global Central Lab Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 02: Global Central Lab Market Value (US$ Mn) Forecast, by End-user, 2017‒2031

Table 03: Global Central Lab Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 04: North America Central Lab Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 05: North America Central Lab Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 06: North America Central Lab Market Value (US$ Mn) Forecast, by End-user, 2017‒2031

Table 07: Europe Central Lab Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031

Table 08: Europe Central Lab Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 09: Europe Central Lab Market Value (US$ Mn) Forecast, by End-user, 2017‒2031

Table 10: Asia Pacific Central Lab Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031

Table 11: Asia Pacific Central Lab Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 12: Asia Pacific Central Lab Market Value (US$ Mn) Forecast, by End-user, 2017‒2031

Table 13: Latin America Central Lab Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031

Table 14: Latin America Central Lab Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 15: Latin America Central Lab Market Value (US$ Mn) Forecast, by End-user, 2017‒2031

Table 16: Middle East & Africa Central Lab Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031

Table 17: Middle East & Africa Central Lab Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 18: Middle East & Africa Central Lab Market Value (US$ Mn) Forecast, by End-user, 2017‒2031

List of Figures

Figure 01: Global Central Lab Market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Global Central Lab Market Value Share, by Product, 2020

Figure 03: Global Central Lab Market Value Share, by End-user, 2020

Figure 04: Global Central Lab Market Value Share, by Region, 2020

Figure 05: Global Central Lab Market Value Share Analysis, by Product, 2020 and 2031

Figure 06: Global Central Lab Market Attractiveness Analysis, by Product, 2021–2031

Figure 07: Global Central Lab Market Revenue (US$ Mn), by Genetic Services, 2017–2031

Figure 08: Global Central Lab Market Revenue (US$ Mn), by Biomarker Services, 2017–2031

Figure 09: Global Central Lab Market Revenue (US$ Mn), by Microbiology Services, 2017–2031

Figure 10: Global Central Lab Market Revenue (US$ Mn), by Anatomic Pathology/Histology, 2017–2031

Figure 11: Global Central Lab Market Revenue (US$ Mn), by Specimen Management & Storage, 2017–2031

Figure 12: Global Central Lab Market Revenue (US$ Mn), by Special Chemistry Services, 2017–2031

Figure 13: Global Central Lab Market Revenue (US$ Mn), by Clinical Research & Trial Services, 2017–2031

Figure 14: Global Central Lab Market Revenue (US$ Mn), by Others, 2017–2031

Figure 15: Global Central Lab Market Value Share Analysis, by End-user, 2020 and 2031

Figure 16: Global Central Lab Market Attractiveness Analysis, by End-user, 2021–2031

Figure 17: Global Central Lab Market Revenue (US$ Mn), by Pharmaceutical Companies, 2017–2031

Figure 18: Global Central Lab Market Revenue (US$ Mn), by Biotechnology Companies, 2017–2031

Figure 19: Global Central Lab Market Revenue (US$ Mn), by Academic and Research Institutes, 2017–2031

Figure 20: Global Central Lab Market Value Share Analysis, by Region, 2020 and 2031

Figure 21: Global Central Lab Market Attractiveness Analysis, by Region, 2021–2031

Figure 22: North America Central Lab Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 23: North America Central Lab Market Value Share Analysis, by Country, 2020 and 2031

Figure 24: North America Central Lab Market Attractiveness Analysis, by Country, 2021–2031 

Figure 25: North America Central Lab Market Value Share Analysis, by Product, 2020 and 2031

Figure 26: North America Central Lab Market Attractiveness Analysis, by Product, 2021–2031

Figure 27: North America Central Lab Market Value Share Analysis, by End-user, 2020 and 2031

Figure 28: North America Central Lab Market Attractiveness Analysis, by End-user, 2021–2031

Figure 29: Europe Central Lab Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 30: Europe Central Lab Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 31: Europe Central Lab Market Attractiveness Analysis, by Country/Sub-region, 2021–2031 

Figure 32: Europe Central Lab Market Value Share Analysis, by Product, 2020 and 2031

Figure 33: Europe Central Lab Market Attractiveness Analysis, by Product, 2021–2031

Figure 34: Europe Central Lab Market Value Share Analysis, by End-user, 2020 and 2031

Figure 35: Europe Central Lab Market Attractiveness Analysis, by End-user, 2021–2031

Figure 36: Asia Pacific Central Lab Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 37: Asia Pacific Central Lab Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 38: Asia Pacific Central Lab Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 39: Asia Pacific Central Lab Market Value Share Analysis, by Product, 2020 and 2031

Figure 40: Asia Pacific Central Lab Market Attractiveness Analysis, by Product, 2021–2031

Figure 41: Asia Pacific Central Lab Market Value Share Analysis, by End-user, 2020 and 2031

Figure 42: Asia Pacific Central Lab Market Attractiveness Analysis, by End-user, 2021–2031

Figure 43: Latin America Central Lab Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 44: Latin America Central Lab Market Value Share Analysis, by Country, 2020 and 2031

Figure 45: Latin America Central Lab Market Attractiveness Analysis, by Country, 2021–2031 

Figure 46: Latin America Central Lab Market Value Share Analysis, by Product, 2020 and 2031

Figure 47: Latin America Central Lab Market Attractiveness Analysis, by Product, 2021–2031

Figure 48: Latin America Central Lab Market Value Share Analysis, by End-user, 2020 and 2031

Figure 49: Latin America Central Lab Market Attractiveness Analysis, by End-user, 2021–2031

Figure 50: Middle East & Africa Central Lab Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 51: Middle East & Africa Central Lab Market Value Share Analysis, by Country, 2020 and 2031

Figure 52: Middle East & Africa Central Lab Market Attractiveness Analysis, by Country, 2021–2031

Figure 53: Middle East & Africa Central Lab Market Value Share Analysis, by Product, 2020 and 2031

Figure 54: Middle East & Africa Central Lab Market Attractiveness Analysis, by Product, 2021–2031

Figure 55: Middle East & Africa Central Lab Market Value Share Analysis, by End-user, 2020 and 2031

Figure 56: Middle East & Africa Central Lab Market Attractiveness Analysis, by End-user, 2021–2031

Figure 57: Global Central Lab Market Share, by Company, 2020

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

933

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved